drugset / Trial / NCT01550926
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to determine whether a new dosage form and dose of orlistat is equivalent to the currently marketed form.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Orlistat | Small molecule | 60 mg | — |
| Comparator | Orlistat | Small molecule | 120 mg | — |